Myopia Progression in Children: What Actually Slows It Down

Myopia is a shape, not just a number

Childhood myopia is usually described as a prescription that keeps getting stronger. The underlying event is structural: the eyeball grows too long for its own optics, so light from a distant object focuses in front of the retina instead of on it. That process is called axial elongation, and it is the reason a child's prescription changes from year to year while an adult's typically does not.

The numbers behind it are worth knowing. In a growing eye, roughly one millimetre of extra axial length corresponds to about 2.5 to 3 dioptres of myopia — equivalently, about 0.35 to 0.40 mm per dioptre. So a change of one dioptre a year, which is common in a school-age child, represents a genuinely small physical change happening steadily. It also explains why the two interventions that matter most are not lenses at all: they act on the growth signal, not on the blur.

Why the eye keeps growing

The retina uses blur as feedback. If images focus behind the retina, the eye is thought to interpret that as a signal to grow longer, which brings the focus forward. The complication is that this feedback is local rather than global: the retina evaluates blur in each region separately, including the periphery. A standard single-vision lens corrects the centre of the field of view but can leave light in the periphery focusing behind the retina, which is the basis of the peripheral defocus hypothesis. It is the main explanation for why a lens that makes the centre of vision sharp might still be sending a growth signal at the edges.

This is why the optical interventions used for children are not simply weaker or stronger versions of ordinary glasses. They are designed to change where light focuses outside the centre. The same logic sits behind orthokeratology, where a rigid lens worn overnight temporarily reshapes the front surface of the cornea, and behind specially designed contact lenses.

What the evidence actually supports

Several approaches are studied for slowing progression, and they are not equivalent in evidence or in practicality. Defocus spectacle and contact lenses aim to alter peripheral focus. Orthokeratology has a substantial body of evidence for slowing axial elongation in children. Low-concentration atropine eye drops are used by eye-care professionals in some countries, and their use depends on clinical assessment rather than a general rule. Because these are medical decisions with real trade-offs, the correct place to weigh them is a consultation, not an article.

The one factor that appears consistently and is not a device is time outdoors. Children who spend more time outside tend to develop myopia less often and, in some studies, progress more slowly. The mechanism is debated — brighter light and different spectral conditions outdoors are both proposed, along with the simple fact that time outside displaces prolonged near work. What matters practically is that this is a low-risk, general recommendation, while the optical and pharmacological options are not something to self-select.

Why "just get stronger glasses" is not the whole answer

Standard single-vision glasses do the essential job: they put the centre of the visual field in focus so the child can see the board and read comfortably. What they do not do is address the growth signal. That is not a failure of glasses — it is a different objective. Correcting vision and managing progression are two goals that need to be discussed separately, and the second one is a clinical conversation.

How progression is measured

Refraction alone is a blunt instrument, because it depends on how the eye was measured and on how much attention the child paid during the test. The more direct measure is axial length, taken with an optical biometer — a quick, non-contact scan. Two children whose prescriptions both moved by one dioptre in a year may have had quite different changes in eye length, and it is eye length that carries the long-term risk. This is why clinics that manage myopia record axial length at intervals rather than relying on the prescription alone, and it gives a fairer way to judge whether a strategy is working: a change in the rate of growth over time, rather than a single reading.

Common misconceptions

When to see an eye-care professional

Squinting, sitting very close to a screen, headaches after reading, or a teacher reporting that a child cannot see the board are all reasons to book an examination rather than to guess a prescription. Myopia in a young child, a family history of high myopia, or a change of more than about a dioptre in a year are reasons to ask specifically about progression management. Sudden flashes, floaters, a curtain across the vision, or a sudden drop in vision need prompt attention rather than a routine appointment. An optometrist can measure axial length and progression over time, which is the only way to judge whether a strategy is working.